WILLIAM GIUNTA: Open Payments
NPI 1518677285 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 33 payments from 11 companies in 2025. Trend: 2023 $16 · 2024 $15 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Amgen Inc. | 5 | $90 |
| Exact Sciences Corporation | 3 | $56 |
| PFIZER INC. | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Dexcom, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, Wegovy, OTEZLA, Cologuard Collection Kit, PREVNAR 20, AIRSUPRA, TRELEGY ELLIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
